568 related articles for article (PubMed ID: 33388347)
1. Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
Ishida K; Kaji K; Sato S; Ogawa H; Takagi H; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
J Nutr Biochem; 2021 Mar; 89():108573. PubMed ID: 33388347
[TBL] [Abstract][Full Text] [Related]
2. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.
Fujimoto Y; Kaji K; Nishimura N; Enomoto M; Murata K; Takeda S; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
World J Gastroenterol; 2021 Dec; 27(48):8323-8342. PubMed ID: 35068872
[TBL] [Abstract][Full Text] [Related]
3. 6-(Methylsulfinyl)hexyl isothiocyanate protects acetaldehyde-caused cytotoxicity through the induction of aldehyde dehydrogenase in hepatocytes.
Kitakaze T; Yuan S; Inoue M; Yoshioka Y; Yamashita Y; Ashida H
Arch Biochem Biophys; 2020 Jun; 686():108329. PubMed ID: 32151565
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.
Kwon HJ; Won YS; Park O; Chang B; Duryee MJ; Thiele GE; Matsumoto A; Singh S; Abdelmegeed MA; Song BJ; Kawamoto T; Vasiliou V; Thiele GM; Gao B
Hepatology; 2014 Jul; 60(1):146-57. PubMed ID: 24492981
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.
Li JP; Gao Y; Chu SF; Zhang Z; Xia CY; Mou Z; Song XY; He WB; Guo XF; Chen NH
Acta Pharmacol Sin; 2014 Aug; 35(8):1031-44. PubMed ID: 24976156
[TBL] [Abstract][Full Text] [Related]
6. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.
Zhu Z; Hu R; Li J; Xing X; Chen J; Zhou Q; Sun J
Int Immunopharmacol; 2021 Jul; 96():107660. PubMed ID: 33862553
[TBL] [Abstract][Full Text] [Related]
7. Pelargonidin ameliorates CCl
Shi YS; Li XX; Li HT; Zhang Y
Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
[TBL] [Abstract][Full Text] [Related]
8. Esculin inhibits hepatic stellate cell activation and CCl
Xu S; Chen Y; Miao J; Li Y; Liu J; Zhang J; Liang J; Chen S; Hou S
Phytomedicine; 2024 Jun; 128():155465. PubMed ID: 38471319
[TBL] [Abstract][Full Text] [Related]
9. RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway.
Shi H; Duan X; Dong J; Tao Y; Lei Y
J Ethnopharmacol; 2024 May; 326():117963. PubMed ID: 38387680
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
[TBL] [Abstract][Full Text] [Related]
11. A polysaccharide from Alhagi honey protects the intestinal barrier and regulates the Nrf2/HO-1-TLR4/MAPK signaling pathway to treat alcoholic liver disease in mice.
Song J; Zhao X; Bo J; Lv Z; Li G; Chen Y; Liang J; Zhang C; Jin X; Liu C; Chang J
J Ethnopharmacol; 2024 Mar; 321():117552. PubMed ID: 38072293
[TBL] [Abstract][Full Text] [Related]
12. Activation of imidazoline I
Zhang W; Li X; Liu Y; Chen H; Gong J
Biomed Pharmacother; 2017 Jun; 90():821-834. PubMed ID: 28437886
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway.
Qi T; Xu F; Yan X; Li S; Li H
Int J Mol Med; 2016 Jan; 37(1):182-8. PubMed ID: 26531002
[TBL] [Abstract][Full Text] [Related]
14. Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling.
Ge C; Tan J; Lou D; Zhu L; Zhong Z; Dai X; Sun Y; Kuang Q; Zhao J; Wang L; Liu J; Wang B; Xu M
Redox Biol; 2022 May; 51():102274. PubMed ID: 35240537
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
Ceni E; Mello T; Galli A
World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways.
Zhao HW; Zhang ZF; Chai X; Li GQ; Cui HR; Wang HB; Meng YK; Liu HM; Wang JB; Li RS; Bai ZF; Xiao XH
Int Immunopharmacol; 2016 Jul; 36():249-255. PubMed ID: 27179304
[TBL] [Abstract][Full Text] [Related]
17. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease.
Hao L; Sun Q; Zhong W; Zhang W; Sun X; Zhou Z
Redox Biol; 2018 Apr; 14():626-636. PubMed ID: 29156373
[TBL] [Abstract][Full Text] [Related]
19. The functional role of microRNAs in alcoholic liver injury.
McDaniel K; Herrera L; Zhou T; Francis H; Han Y; Levine P; Lin E; Glaser S; Alpini G; Meng F
J Cell Mol Med; 2014 Feb; 18(2):197-207. PubMed ID: 24400890
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane Inhibits Lipopolysaccharide-Induced Inflammation, Cytotoxicity, Oxidative Stress, and miR-155 Expression and Switches to Mox Phenotype through Activating Extracellular Signal-Regulated Kinase 1/2-Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway in Murine Microglial Cells.
Eren E; Tufekci KU; Isci KB; Tastan B; Genc K; Genc S
Front Immunol; 2018; 9():36. PubMed ID: 29410668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
